Tvardi Therapeutics (TVRD) Non-Current Assets (2013 - 2026)
Tvardi Therapeutics (TVRD) reported Non-Current Assets of $448,000 for Q2 2026, down 27.7% from $620,000 a year earlier and down 8.8% from the prior quarter.
Powered by 
Analysis
Tvardi Therapeutics (TVRD) Non-Current Assets (2013 - 2026) Analysis & Trends
At the end of FY2025, Tvardi Therapeutics posted Non-Current Assets of $535,000, down 84.8% from FY2024.
- Non-Current Assets has declined for five consecutive years, with a five-year compound annual growth rate of -62.9% (FY2020 to FY2025).
- By year, Non-Current Assets came in at $3.51 million in FY2024 (-63.7%), $9.69 million in FY2023 (-27.3%), $13.33 million in FY2022 (-81.9%) and $73.77 million in FY2021 (-3.1%).
- The Q2 2026 figure ranks as the lowest quarterly Non-Current Assets in data going back to Q4 2013.
- The high point for year-over-year Non-Current Assets in five years was Q3 2021 (growth of 274.8%); the low point was Q2 2025 (a decline of 92.8%).
- Per Business Quant data, the three quarters before Q2 2026 came in at $491,000 (Q1 2026), $535,000 (Q4 2025) and $578,000 (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Assets (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 141.29 Bn |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 101.45 Bn |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 125.00 Mn |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 94.68 Bn |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 87.87 Bn |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 60.68 Bn |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 35.42 Bn |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 159.77 Bn |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 14.88 Bn |
| 10 | Tvardi Therapeutics | 12.48 Mn | 12.48 Mn | - | 448,000.00 |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 448,000.00 |
| Mar 31, 2026 | 491,000.00 |
| Dec 31, 2025 | 535,000.00 |
| Sep 30, 2025 | 578,000.00 |
| Jun 30, 2025 | 620,000.00 |
| Dec 31, 2024 | 3.51 Mn |
| Sep 30, 2024 | 3.42 Mn |
| Jun 30, 2024 | 8.64 Mn |
| Mar 31, 2024 | 8.87 Mn |
| Dec 31, 2023 | 9.69 Mn |
| Sep 30, 2023 | 14.74 Mn |
| Jun 30, 2023 | 9.65 Mn |
| Mar 31, 2023 | 10.62 Mn |
| Dec 31, 2022 | 13.33 Mn |
| Sep 30, 2022 | 26.73 Mn |
| Jun 30, 2022 | 50.41 Mn |
| Mar 31, 2022 | 72.10 Mn |
| Dec 31, 2021 | 73.77 Mn |
| Sep 30, 2021 | 53.59 Mn |
| Jun 30, 2021 | 56.98 Mn |
API Access
Tvardi Therapeutics Non-Current Assets API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=non-current-assets&ticker=TVRD&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "non-current-assets", "ticker": "TVRD", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=non-current-assets&ticker=TVRD&period=max&api_key=YOUR_API_KEY");
const data = await res.json();